ASSERTIO THERAPEUTICS, INC. Deferred Tax Assets, Net of Valuation Allowance
ASSERTIO THERAPEUTICS, INC. had Deferred Tax Assets, Net of Valuation Allowance of $12.99 million as of 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2020-03-10
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $12.99M.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $12.40M.
- 2017-12-31: Deferred Tax Assets, Net of Valuation Allowance $16.14M.
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance $31.71M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2019-12-31 | $12.99M 10-K · filed 2020-03-10 | |
| 2018-12-31 | $12.40M 10-K · filed 2020-03-10 | |
| 2017-12-31 | $16.14M 10-K · filed 2019-03-11 | |
| 2016-12-31 | $31.71M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $59.98M 10-K · filed 2017-02-24 | |
| 2014-12-31 | $18.95M 10-K · filed 2016-02-26 | -$22.99M 10-K · filed 2015-02-26 |
| 2013-12-31 | $103.20M 10-K · filed 2015-02-26 |